Literature DB >> 26244788

Costs of venous thromboembolism associated with hospitalization for medical illness.

Kevin P Cohoon, Cynthia L Leibson, Jeanine E Ransom, Aneel A Ashrani, Tanya M Petterson, Kirsten Hall Long, Kent R Bailey, Johm A Heit1.   

Abstract

OBJECTIVES: To determine population-based estimates of medical costs attributable to venous thromboembolism (VTE) among patients currently or recently hospitalized for acute medical illness. STUDY
DESIGN: Population-based cohort study conducted in Olmsted County, Minnesota.
METHODS: Using Rochester Epidemiology Project (REP) resources, we identified all Olmsted County residents with objectively diagnosed incident VTE during or within 92 days of hospitalization for acute medical illness over the 18-year period of 1988 to 2005 (n=286). One Olmsted County resident hospitalized for medical illness without VTE was matched to each case for event date (±1 year), duration of prior medical history, and active cancer status. Subjects were followed forward in REP provider-linked billing data for standardized, inflation-adjusted direct medical costs (excluding outpatient pharmaceutical costs) from 1 year before their respective event or index date to the earliest of death, emigration from Olmsted County, or December 31, 2011 (study end date). We censored follow-up such that each case and matched control had similar periods of observation. We used generalized linear modeling (controlling for age, sex, preexisting conditions, and costs 1 year before index) to predict costs for cases and controls.
RESULTS: Adjusted mean predicted costs were 2.5-fold higher for cases ($62,838) than for controls ($24,464) (P<.001) from index to up to 5 years post index. Cost differences between cases and controls were greatest within the first 3 months after the event date (mean difference=$16,897) but costs remained significantly higher for cases compared with controls for up to 3 years.
CONCLUSIONS: VTE during or after recent hospitalization for medical illness contributes a substantial economic burden.

Entities:  

Mesh:

Year:  2015        PMID: 26244788      PMCID: PMC4586032     

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  34 in total

1.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Cynthia L Leibson; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations.

Authors:  Alex C Spyropoulos; Jay Lin
Journal:  J Manag Care Pharm       Date:  2007 Jul-Aug

3.  Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States.

Authors:  Richard H White; Martina Garcia; Banafsheh Sadeghi; Daniel J Tancredi; Patricia Zrelak; Joanne Cuny; Pradeep Sama; Harriet Gammon; Stephen Schmaltz; Patrick S Romano
Journal:  Thromb Res       Date:  2010-04-28       Impact factor: 3.944

4.  The economics of coeliac disease: a population-based study.

Authors:  K H Long; A Rubio-Tapia; A E Wagie; L J Melton; B D Lahr; C T Van Dyke; J A Murray
Journal:  Aliment Pharmacol Ther       Date:  2010-04-08       Impact factor: 8.171

5.  Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.

Authors:  Drahomir Aujesky; Pierre-Marie Roy; Franck Verschuren; Marc Righini; Joseph Osterwalder; Michael Egloff; Bertrand Renaud; Peter Verhamme; Roslyn A Stone; Catherine Legall; Olivier Sanchez; Nathan A Pugh; Alfred N'gako; Jacques Cornuz; Olivier Hugli; Hans-Jürg Beer; Arnaud Perrier; Michael J Fine; Donald M Yealy
Journal:  Lancet       Date:  2011-06-22       Impact factor: 79.321

6.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

7.  Do coder characteristics influence validity of ICD-10 hospital discharge data?

Authors:  Deirdre A Hennessy; Hude Quan; Peter D Faris; Cynthia A Beck
Journal:  BMC Health Serv Res       Date:  2010-04-21       Impact factor: 2.655

8.  Identifying in-hospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort.

Authors:  Cynthia L Leibson; Jack Needleman; Peter Buerhaus; John A Heit; L Joseph Melton; James M Naessens; Kent R Bailey; Tanya M Petterson; Jeanine E Ransom; Marcelline R Harris
Journal:  Med Care       Date:  2008-02       Impact factor: 2.983

9.  Determinants of direct cost differences among US employees with major depressive disorders using antidepressants.

Authors:  Howard G Birnbaum; Rym Ben-Hamadi; Paul E Greenberg; Matthew Hsieh; Jackson Tang; Camille Reygrobellet
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.

Authors:  Dominick Esposito; Ann D Bagchi; James M Verdier; Deo S Bencio; Myoung S Kim
Journal:  Am J Manag Care       Date:  2009-07       Impact factor: 2.229

View more
  10 in total

1.  Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study.

Authors:  Kevin P Cohoon; Cynthia L Leibson; Jeanine E Ransom; Aneel A Ashrani; Myung S Park; Tanya M Petterson; Kirsten Hall Long; Kent R Bailey; John A Heit
Journal:  Surgery       Date:  2015-01-26       Impact factor: 3.982

2.  Direct Medical Costs Attributable to Cancer-Associated Venous Thromboembolism: A Population-Based Longitudinal Study.

Authors:  Kevin P Cohoon; Jeanine E Ransom; Cynthia L Leibson; Aneel A Ashrani; Tanya M Petterson; Kirsten Hall Long; Kent R Bailey; John A Heit
Journal:  Am J Med       Date:  2016-03-21       Impact factor: 4.965

3.  Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial.

Authors:  Jeffrey I Zwicker; Joanna Roopkumar; Maneka Puligandla; Benjamin L Schlechter; Anish V Sharda; David Peereboom; Robin Joyce; Bruno Bockorny; Donna Neuberg; Kenneth A Bauer; Alok A Khorana
Journal:  Blood Adv       Date:  2020-05-26

Review 4.  Epidemiology of venous thromboembolism.

Authors:  John A Heit
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

5.  Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews.

Authors:  Andrea J Darzi; Allen B Repp; Frederick A Spencer; Rami Z Morsi; Rana Charide; Itziar Etxeandia-Ikobaltzeta; Kenneth A Bauer; Allison E Burnett; Mary Cushman; Francesco Dentali; Susan R Kahn; Suely M Rezende; Neil A Zakai; Arnav Agarwal; Samer G Karam; Tamara Lotfi; Wojtek Wiercioch; Reem Waziry; Alfonso Iorio; Elie A Akl; Holger J Schünemann
Journal:  Blood Adv       Date:  2020-10-13

Review 6.  The epidemiology of venous thromboembolism.

Authors:  John A Heit; Frederick A Spencer; Richard H White
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

7.  Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA.

Authors:  Alpesh Amin; W Richey Neuman; Melissa Lingohr-Smith; Brandy Menges; Jay Lin
Journal:  Drugs Context       Date:  2019-01-21

8.  Physicians' Views on Utilization of an Electronic Health Record-Embedded Calculator to Assess Risk for Venous Thromboembolism among Medical Inpatients: A Qualitative Study.

Authors:  Stephanie R Moss; Kathryn A Martinez; Cassandra Nathan; Elizabeth R Pfoh; Michael B Rothberg
Journal:  TH Open       Date:  2022-01-24

9.  Risk Factors of Venous Thromboembolism in Patients With Lung Cancer Before Surgery: A Case Control Study.

Authors:  Fangyuan Zhang; Lifeng Liu; Yongsheng Sha
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

10.  A significant proportion of venous thromboembolism events in general surgical patients occurs after discharge: analysis of the ACS-NSQIP Essentials database.

Authors:  Abdelghaffar K Salous; Ashraf Reyad; Karen Sweeney; Arun Mavanur
Journal:  Perioper Med (Lond)       Date:  2019-12-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.